Related references
Note: Only part of the references are listed.The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins
Miao Hu et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Molecular genetic basis for fluoroquinolone-induced retinal degeneration in cats
Christina J. Ramirez et al.
PHARMACOGENETICS AND GENOMICS (2011)
ABCG2 reduces ROS-mediated toxicity and inflammation: a potential role in Alzheimer's disease
Shanshan Shen et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Feline Degenerative Joint Disease
B. Duncan X. Lascelles
VETERINARY SURGERY (2010)
Physiological and pharmacological roles of ABCG2 (BCRP): Recent findings in Abcg2 knockout mice
Maria L. H. Vlaming et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
ABCG2: A perspective
Robert W. Robey et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
LC-MS/MS Mediated Absolute Quantification and Comparison of Bile Salt Export Pump and Breast Cancer Resistance Protein in Livers and Hepatocytes across Species
Na Li et al.
ANALYTICAL CHEMISTRY (2009)
Functionally Overlapping Roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the Elimination of Methotrexate and Its Main Toxic Metabolite 7-Hydroxymethotrexate In vivo
Maria L. H. Vlaming et al.
CLINICAL CANCER RESEARCH (2009)
Single nucleotide polymorphism in ABCG2 is associated with irinotecan-induced severe myelosuppression
Pei-Chieng Cha et al.
JOURNAL OF HUMAN GENETICS (2009)
Milk secretion of nitrofurantoin, as a specific BCRP/ABCG2 substrate, in assaf sheep: modulation by isoflavones
M. Perez et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2009)
Curcumin Inhibits the Activity of ABCG2/BCRP1, a Multidrug Resistance-Linked ABC Drug Transporter in Mice
Suneet Shukla et al.
PHARMACEUTICAL RESEARCH (2009)
Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout
Owen M. Woodward et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population
Hirotaka Matsuo et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Quantitative investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) in limiting brain and testis penetration of xenobiotic compounds
Junichi Enokizono et al.
DRUG METABOLISM AND DISPOSITION (2008)
Fluoroquinolone efflux mediated by ABC transporters
Ana I. Alvarez et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
The pharmacogenomics of P-glycoprotein and its role in veterinary medicine
M. Martinez et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2008)
Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice
Serena Marchetti et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Pharmacogenomic importance of ABCG2
George Cusatis et al.
PHARMACOGENOMICS (2008)
New inhibitors of ABCG2 identified by high-throughput screening
Curtis J. Henrich et al.
MOLECULAR CANCER THERAPEUTICS (2007)
A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients
Isa E. L. M. Kuppens et al.
CLINICAL CANCER RESEARCH (2007)
ABCG2 membrane transporter in mature human erythrocytes is exclusively homodimer
Mara L. Leimanis et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Pharmacogenetics of ABCG2 and adverse reactions to gefitinib
George Cusatis et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
The important role of Bcrp (Abcg2) in the biliary excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in mice
Maciej J. Zamek-Gliszczynski et al.
MOLECULAR PHARMACOLOGY (2006)
Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): influence of flavonoids and role in milk secretion in sheep
Mivis M. Pulido et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2006)
Pharmacological strategies for overcoming multidrug resistance
S. Nobili et al.
CURRENT DRUG TARGETS (2006)
ATP-binding cassette transporter G2 mediates the efflux of phototoxins on the luminal membrane of retinal capillary endothelial cells
Tomoko Asashima et al.
PHARMACEUTICAL RESEARCH (2006)
Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion
G Merino et al.
DRUG METABOLISM AND DISPOSITION (2006)
Breast cancer resistance protein (Bcrp/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse
Hani Zaher et al.
MOLECULAR PHARMACEUTICS (2006)
Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk
AE van Herwaarden et al.
CARCINOGENESIS (2006)
Single nucleotide polymorphisms modify the transporter activity of ABCG2
K Morisaki et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Identification of a missense mutation in the bovine ABCG2 gene with a major effect on the QTL on chromosome 6 affecting milk yield and composition in Holstein cattle
M Cohen-Zinder et al.
GENOME RESEARCH (2005)
The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin
G Merino et al.
MOLECULAR PHARMACOLOGY (2005)
Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense
EM Leslie et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels
S Zhou et al.
BLOOD (2005)
Single amino acid (482) variants of the ABCG2 multidrug transporter:: major differences in transport capacity and substrate recognition
C Özvegy-Lacka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2005)
The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk
JW Jonker et al.
NATURE MEDICINE (2005)
Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles:: Potential role for breast cancer resistance protein in clinical drug-drug interactions
P Breedveld et al.
CANCER RESEARCH (2004)
Therapeutic implications of the MDR-1 gene
KL Mealey
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2004)
The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria
JW Jonker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918
CMF Kruijtzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2)
RW Robey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan
JW Jonker et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Molecular genetic basis for deficient acetaminophen glucuronidation by cats: UGT1A6 is a pseudogene, and evidence for reduced diversity of expressed hepatic UGT1A isoforms
MH Court et al.
PHARMACOGENETICS (2000)
Share Paper
